| Overview |
| bsm-62841r |
| Phospho-PLB (Ser16) Recombinant Antibody |
| WB |
| Mouse |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human PLB around the phosphorylation site of S16 |
| Ser166 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 5350 |
| P26678 |
| Cardiac phospholamban; CMD1P; CMH18; PLB; Pln. |
| Reversibly inhibits the activity of ATP2A2 in cardiac sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca(2+). Modulates the contractility of the heart muscle in response to physiological stimuli via its effects on ATP2A2. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz